SLF2 and diffuse large B-cell lymphoma: Moreover, low SLF2 expression was associated with the adverse prognosis of DLBCL patients (Fig 3B, Appendix Fig S4), which was not observed for SMC5‐SMC6 Complex Localization Factor 1 (SLF1; Fig 3C).